DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma

Environmental and Molecular Mutagenesis

Volumn 40, Issue 3, 2002, Pages 190-199

  Gontijo, Álisson Marques De Miranda Cabral ^a   Marcondes, João Paulo De Castro ^a   Elias, Flávia Nunes ^a   De Oliveira, Maria Luiza Cotrim Sartor ^a   De Lima, Rodrigo Otávio Alves ^a   Salvadori, Daisy Maria Favero ^a   De Camargo, João Lauro Viana ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cancer management; DNA content; DNA damage; Micranucleated urothelial cells; Transitional cell carcinoma; Tumor recurrence

Indexed keywords

DNA;

ADULT; AGE; AGED; ANAMNESIS; ANEUPLOIDY; ARTICLE; BLADDER IRRIGATION; CANCER GRADING; COMET ASSAY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DNA DAMAGE; EPITHELIUM CELL; FLUORESCENCE; GENETIC STABILITY; GIEMSA STAIN; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICRONUCLEUS; SMEAR; SMOKING; STATISTICAL SIGNIFICANCE; TIME; URINE CYTOLOGY; UROGENITAL TRACT CANCER; UROTHELIAL CELL CARCINOMA; UROTHELIUM;

ADULT; AGE FACTORS; AGED; CARCINOMA; COMET ASSAY; DNA; DNA DAMAGE; HUMANS; MICRONUCLEUS TESTS; MIDDLE AGED; MUTATION; PHENOTYPE; SMOKING; TIME FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0036395943     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10109     Document Type: Article

References (44)

1. Abel PD. 1998. Prognostic indices in transitional cell carcinoma of the bladder. Br J Urol 62:103-109.
2. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG, Tice R, Waters MD, Aitio A. 2000. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111-172.
3. Bellaoui H, Chefchaouni MC, Lazrak N, Khalfaoui LC, Yassine F, Elhamany Z. 2002. Flow cytometric DNA analysis and cytology in diagnosis and prognosis of bladder tumors: preliminary results of a comparative study of bladder lavage. Ann Urol (Paris) 36:45-52.
4. Belyakov OV, Prise KM, Trott KR, Michael BD. 1999. Delayed lethality, apoptosis and micronucleus formation in human fibroblasts irradiated with X-rays or alpha-particles. Int J Radiat Biol 75:985-993.
5. Bertram JS. 2000. The molecular biology of cancer. Mol Aspects Med 21:167-223.
6. Bruno S, Torrisi R, Costantini M, Baglietto L, Fontana V, Gatteschi B, Melioli G, Nicolo G, Curotto A, Malcangi B, Bruttini GP, Varaldo M, Bruzzi P, Decensi A. 1999. Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial. J Cell Biochem 76:311-321.
7. Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV. 1999. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Oncogene 18:5611-5619.
8. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, Miller, AB. 1989. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 44:622-628.
9. Chang WP, Tsai MS, Hwang JS, Lin YP, Hsieh WA, Huang SY. 1999 Follow-up in the micronucleus frequencies and its subsets in human population with chronic low-dose gamma-irradiation exposure. Mutat Res 428:99-105.
10. Chern H-D, Becich MJ, Persa RA, Romkes M, Smith P, Collins C, Li Y-H, Branch RB. 1996. Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins. J Urol 156:1846-1849.
11. Cohen SM. 1998. Urinary bladder carcinogenesis. Toxicol Pathol 26:121-127.
12. Cotran RS, Kumar V, Collins T. 1999. The lower urinary tract. In: Cotran RS, Kumar V, Collins T, editors. Robbins pathologic basis of disease, 6th ed. Philadelphia: WB Saunders. p 997-1010.
13. Dar ME, Jorgensen TJ. 1995. Deletions at short direct repeats and base substitutions are characteristic mutations for bleomycin-induced double- and single-strand breaks, respectively, in a human shuttle vector system. Nucleic Acids Res 23:3224-3230.
14. Epstein JI, Amin MB, Reuter VR, Mostofi FK. 1998. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surgical Pathol 22:1435-1448.
15. Gontijo ÁMMC, Elias FN, Salvadori DMF, de Oliveira MLCS, Correa LA, Goldberg J, Trindade LCS, de Camargo JLV. 2001. Single-cell gel (comet) assay detects primary DNA damage in urothelial cells of smokers and ex-smokers. Cancer Epidemiol Biomark Prev 10:987-993.
16. Gonzales-Cid LD, Loria D, Vilensky M, Miotti J, Matos E. 1991. Leather tanning workers: chromosomal aberrations in peripheral lymphocytes and micronuclei in exfoliated cells in urine. Mutat Res 259:197-201.
17. Hagmar L, Bonassi S, Stömberg U, Brogger A, Knudsen LE, Norppa H, Reuterwall C. 1998. Chromosomal aberations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117-4121.
18. Han M, Schoenberg MP. 2000. The use of molecular diagnostics in bladder cancer. Urol Oncol 5:87-92.
19. Herr HW. 1997. Natural history of superficial bladder tumors B 10- to 20-year follow-up of treated patients. World J Urol 15:84-88.
20. Ioakim-Liossi A, Pantazopoulos D, Karakitsos P, Athanassiadou P, Aroni K, Chourdakis N, Giachnaki A, Athanassiades P. 2000. DNA ploidy and p53 protein expression in superficial transitional cell carcinoma of the bladder. Cytopathology 11:96-103.
21. Jackson AL, Loeb LA. 2001. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 477:7-21.
22. Lehucher-Michel MP, Di Giorgio C, Amara YA, Laget M, Botta A. 1995. The micronucleus assay in human exfoliated urothelial cells: effect of smoking. Mutagenesis 10:329-332.
23. Limoli CL, Kaplan MI, Phillips JW, Adair GM, Morgan, WF. 1997. Differential induction of chromosomal instability by DNA strand-breaking agents. Cancer Res 57:4048-4056.
24. Loeb LA. 2001. A mutator phenotype in cancer. Cancer Res 61:3230-3239.
25. Maluf SW, Erdtmann B. 2001. Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis. Cancer Genet Cytogenet 124:71-75.
26. McKelvey-Martin VJ, Melia N, Walsh IK, Johnston SR, Hughes CM, Lewis SEM, Thompson W. 1997. Two potential clinical applications of the alkaline single-cell gel electrophoresis assay: (1) human bladder washings and transitional cell carcinoma of the bladder: and (2) human sperm and male infertility. Mutat Res 375:93-104.
27. Mostofi FK. 1974. International histologic classification of tumors. A report by the Executive Committee of the International Council of Societies of Pathology. Cancer 33:1480-1484.
28. Olive PL, Banáth JP. 1993. Induction and rejoining of radiation-induced DNA single-strand breaks: "tail moment" as a function of position in cell cycle. Mutat Res 294:275-283.
29. Olive PL, Banáth JP, Durand RE. 1990. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res 122:86-94.
30. Qureshi KN, Naguib RN, Hamdy FC, Neal DE, Mellon JK. 2000. Neural network analysis of clinicopathological and molecular markers in bladder cancer. J Urol 163:630-633.
31. Reznikoff CA, Sarkar S, Jülicher KP, Burger MS, Puthenveettil JA, Jarrard DF, Newton MA. 2000. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol 5:191-203.
32. Ribeiro L, Cerqueira E, Salvadori D, Barbosa H, Whorton E. 1990. Biomonitoring of individuals occupationally exposed to aromatic amines. In: Mutation and the environment, part C. New York: Wiley-Liss. p 387-396.
33. Rothfuss A, Stahl W, Radermacher P, Speit G. 1999. Evaluation of mutagenic effects of hyperbaric oxygen (HBO) in vitro. Environ Mol Mutagen 34:291-296.
34. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. 1992. Clonal origin bladder cancer. N Engl J Med 326:737-740.
35. Simon R, Eltze E, Schäfer K-L, Bürger H, Semjonow A, Hertle L, Dockhorn-Dworniczak B, Terpe H-J, B6cker W. 2001. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61:355-362.
36. Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
37. Steiner G, Schoenberg MP, Linn JF, Mao L, Sidransky D. 1997. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 6:621-624.
38. Stich H, Stich W, Rosin M. 1985. The micronucleus test on exfoliated human cells. Basic Life Sci 34:337-342.
39. Takahashi M. 1981. Urinary tract. In: Takahashi, M, editor. Color atlas of cancer cytology, 2nd ed. Tokyo: IGAKU-SHOIN. p 459-505.
40. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221.
41. Tredaniel J, Boffetta P, Saracci R, Hirsch A. 1993. Environmental tobacco smoke and the risk of cancer in adults. Eur J Cancer 29A:2058-2068.
42. Trenz K, Rothfuss A, Schutz P, Speit G. 2002. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat Res 500:89-96.
43. Villani P, Altavista PL, Castaldi L, Leter G, Cordelli E. 2000. Analysis of DNA oxidative damage related to cell proliferation. Mutat Res 464:229-237.
44. Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402:187-191.